A Look At RLX Technology (RLX) Valuation As Q1 2026 Earnings Expectations Draw Investor Focus

Upcoming earnings put RLX Technology (RLX) in focus

RLX Technology (RLX) is set to release first quarter 2026 financial results before the market opens on May 20.

See our latest analysis for RLX Technology.

At a share price of US$2.17, RLX has seen short term share price returns soften, with the 90 day share price return down 7.66%, even as the 1 year total shareholder return sits at 15.89%. This points to fading momentum after earlier gains.

If upcoming earnings have you reassessing where growth could come from next, this can be a useful moment to scan beyond a single stock and review 18 top founder-led companies

With RLX trading at US$2.17 and sitting at a discount to analyst price targets and intrinsic value estimates, the key question is whether this reflects genuine undervaluation or if the market already prices in expectations for the company’s prospects.

Most Popular Narrative: 30.8% Undervalued

At a last close of US$2.17 versus a narrative fair value of about US$3.14, the widely followed view frames RLX as materially discounted, with the gap resting on specific assumptions about growth, margins, and risk.

The ongoing global shift from traditional cigarettes to reduced-risk products, such as e-vapor and oral nicotine, is growing the overall nicotine alternatives market; RLX's leadership and early move into multi-category offerings position it to capture expanding consumer demand, supporting strong long-term revenue growth.

Read the complete narrative.

Curious what earnings path and margin profile support that higher fair value, especially with a lower future P/E baked in. The narrative leans on rising sales, tempered profitability assumptions, and a specific discount rate to bridge today’s price with that target.

Result: Fair Value of $3.14 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that upside story can quickly be challenged if tighter e-vapor regulation or intensifying global competition pressures RLX’s margins more than analysts currently factor in.

Find out about the key risks to this RLX Technology narrative.

Another Angle On Valuation

While the narrative and cash flow view point to upside, the current P/E tells a more mixed story. At 19.6x earnings, RLX trades slightly above its fair ratio of 19.2x and well above the global tobacco industry at 12.6x, yet sits below peer averages around 31.5x. That combination hints at both valuation risk and possible opportunity. Which side do you think matters more?

To put those earnings multiples into context, take a look at our valuation breakdown, which applies that fair ratio and compares RLX against peers and the wider industry using the same lens, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Sentiment around RLX is clearly mixed. This is exactly why it helps to move quickly, look through the numbers yourself, and weigh both sides before deciding how it fits your portfolio, starting with the 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If you only focus on RLX, you could miss other stocks that fit your style, so use this moment to refresh your watchlist with fresh ideas.

• Target potential mispricings by scanning 52 high quality undervalued stocks that pair quality fundamentals with appealing valuations.
• Prioritise resilience with 65 resilient stocks with low risk scores that score well on financial strength and risk metrics.
• Hunt for underfollowed opportunities using the screener containing 21 high quality undiscovered gems that many investors may not be watching yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com